finance and baxter international inc. Resources | BNET
On The Insider: Ricky Martin - Father of Twins!

BNET Industries

Baxter International Inc. (BAX) is in the Health Care Industry

Revenue
Dec 31 2007
$11.2B
Profit
Dec 31 2007
$1.7B
Market Cap
Aug 19 2008
$43.5B

Latest News and Analysis

Additional Resources

  • page 1 of 1
  • Incorporated: 1931
  • CEO: Mr. Robert L. Parkinson Jr.

Baxter International operates via three key business segments. Co.'s BioScience business produces recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as proteins used in hemostasis, wound-sealing and tissue regeneration; and vaccines. In addition, Co.'s Medication Delivery business manufactures products used in the delivery of fluids and drugs to patients, and its Renal business provides products to treat end-stage renal disease, or irreversible kidney failure.

Key Competitors

advertisement
Baxter International Inc. Company Info

Board of Directors

Mr. Robert L. Parkinson Jr.

Chairman

Mr. John D. Forsyth

Ms. Gail D. Fosler

Ms. Carole Uhrich Shapazian

General Walter E. Boomer

Mr. Thomas T. Stallkamp

Lead Director

Dr. Wayne T. Hockmeyer Ph.D.

Dr. Joseph B. Martin M.D., Ph

Mr. Albert P.L. Stroucken

Dr. James R. Gavin III, M.D

Mr. Peter S. Hellman

Mr. Kornelis J. Storm

Mr. Blake E. Devitt

Contact Information

One Baxter Parkway

Deerfield, IL

http://www.baxter.com

847 948-2000

NAICS Code

Surgical and Medical Instrument Manufacturing: 339112
advertisement